Healthcare Dispensing Systems Market - Global Forecast To 2030
商品番号 : SMB-82255
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 406 |
| 図表数 | 467 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
- このレポートでは、タイプ、調剤材料、用途、エンドユーザー、地域に基づいてヘルスケア調剤システム市場を調査します。
- このレポートでは、市場の成長に影響を与える要因（推進要因、制約、機会、課題など）を分析します。
- このレポートでは、利害関係者にとっての市場の機会と課題を評価し、市場リーダーの競争環境の詳細を提供します。
- このレポートでは、マイクロ市場の成長傾向、見通し、ヘルスケア調剤システム市場全体への貢献について調査しています。
- このレポートでは、5 つの主要地域に関して市場セグメントの収益を予測しています。
The healthcare dispensing systems market is projected to reach USD 6.27 billion by 2030 from USD 4.61 billion in 2025, at a CAGR of 6.3% during the forecast period. The growing demand for precision, automation, and efficiency in life sciences and clinical applications drives pharmaceutical and biotechnology companies to shift toward high-throughput screening and personalized medicine. As a result, there is a rising need for accurate and contamination-free liquid handling systems. Concerns about advanced dispensing systems, high costs, and integration issues with other laboratory systems can hinder the growth of the healthcare dispensing systems market to some extent over the forecast period.
ヘルスケアディスペンシングシステム市場は、2025年の46億1,000万米ドルから2030年には62億7,000万米ドルに達し、予測期間中は年平均成長率（CAGR）6.3%で成長すると予測されています。ライフサイエンスおよび臨床アプリケーションにおける精度、自動化、効率性への需要の高まりにより、製薬企業およびバイオテクノロジー企業はハイスループットスクリーニングと個別化医療へとシフトしています。その結果、正確で汚染のない液体処理システムへのニーズが高まっています。高度な分注システム、高コスト、および他のラボシステムとの統合に関する懸念は、予測期間中のヘルスケア分注システム市場の成長をある程度阻害する可能性があります。
“Diagnostic & Point-of-care testing management is the fastest growing application segment in the healthcare dispensing systems market during the forecast period.”
By application, the healthcare dispensing systems market is segmented into pharmaceutical & biotechnology, diagnostic & point-of-care testing management, medical device manufacturing, pharmacy management, and other applications. Among these, the diagnostic & point-of-care testing management is the fastest-growing segment, driven by the increasing demand for rapid, decentralized testing and the global focus on early disease detection. This segment covers applications such as lateral flow assays (LFAs), PCR and NAAT tests, ELISA, microarrays, and microfluidic devices, each requiring accurate and repeatable dispensing of reagents and samples. Growth is fueled by the expansion of molecular diagnostics, rising infectious disease surveillance, and the growing availability of compact, high-throughput testing platforms. The need for precision, speed, and automation in producing consistent diagnostic results has led to the widespread adoption of automated dispensing systems that reduce variability, ensure traceability, and support large-scale manufacturing of test kits.
“Liquids are the fastest growing segment in the healthcare dispensing systems market, by dispensing material, during the forecast period.”
By dispensing material, the healthcare dispensing systems market is segmented into liquids; powders, granules, lyophilized materials; and other dispensing materials. Among these, the liquid segment is projected to grow at the fastest rate during the forecast period due to its critical role in diagnostic, pharmaceutical, and research applications. Liquid dispensing systems are essential for accurately handling reagents, buffers, biological samples, and drug formulations in high-throughput environments. Their precision, speed, and compatibility with automated systems make them indispensable in clinical diagnostics (e.g., ELISA, PCR), pharmaceutical R&D, and point-of-care testing workflows. The increasing demand for automated liquid handling, driven by expanding test volumes, biologics manufacturing, and personalized medicine, has significantly boosted adoption. Additionally, advancements in non-contact and tipless dispensing technologies have enabled greater accuracy and minimized contamination, supporting applications that require stringent quality control. As automation, digitalization, and throughput optimization continue to reshape healthcare and laboratory operations, liquid dispensing systems emerge as a prominent technology, providing scalable, efficient, and compliant fluid handling solutions across diverse end users segments.
“The Asia Pacific region is expected to register the highest growth rate in the healthcare dispensing systems market during the forecast period.”
The global healthcare dispensing systems market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, the Asia Pacific is expected to register the fastest growth in healthcare dispensing systems during the forecast period. This surge is primarily attributed to increased government funding, ongoing expansion in pharmaceutical and diagnostic manufacturing, and the adoption of automation technologies in countries such as China, India, South Korea, and Singapore. Additionally, favorable manufacturing policies, rising foreign direct investment in medtech and biotech sectors, and increased clinical research activity are creating strong demand for high-throughput, automated dispensing solutions. Combined with a focus on improving healthcare accessibility and efficiency, these factors are expected to significantly drive the growth of the healthcare dispensing systems market in Asia Pacific.
The breakdown of primary participants is as mentioned below:
- By Company Type – Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
- By Designation – C-level Executives (44%), Director-level (31%), and Others (25%)
- By Region – North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), Middle East & Africa (3%)
Key Players
The prominent players in this market are Nordson Corporation (US), DH Life Sciences, LLC (US), ABB (Switzerland), Fisnar (US), PARKER HANNIFIN CORP (US), BioDot (US), Thermo Fisher Scientific Inc. (US), bdtronic (Germany), Agilent Technologies, Inc. (US), Hamilton Company (US), Graco Inc. (US), Imagene Technology Inc (US), Harro Höfliger Verpackungsmaschinen GmbH (Germany), Tecan Trading AG (Switzerland), IVEK Corporation (US), Perkinelmer (US), QIAGEN (Germany), Coperion GmbH (Germany), Ascential Technologies (US), and and LGC Biosearch Technologies (UK). Players adopted organic as well as inorganic growth strategies such as product launches and enhancements, and investments, partnerships, collaborations, joint ventures, funding, acquisition, expansions, agreements, contracts, and alliances to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
Research Coverage
- The report studies the healthcare dispensing systems market based on type, dispensing material, application, end user, and region.
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total healthcare dispensing systems market.
- The report forecasts the revenue of market segments with respect to five major regions.
Reasons to Buy the Report
The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.
This report provides insights into the following pointers:
Analysis of key drivers (increasing demand for automation and precision in pharmaceutical and diagnostic workflows, rising adoption of point-of-care and decentralized testing platforms, growing need for high-throughput testing solutions in response to global health challenges, ongoing advancements in liquid handling and non-contact dispensing technologies, expansion of R&D and manufacturing infrastructure by biotech and medtech companies, supportive government initiatives for domestic manufacturing, and the push for digital transformation in clinical laboratories), restraints (high capital investment for advanced dispensing systems, limited adoption in low-resource settings, and technical complexity requiring skilled personnel), opportunities (rising outsourcing of diagnostic manufacturing to contract service providers, increasing investments in personalized medicine and biologics requiring precise micro dispensing, rapid growth in Asia Pacific healthcare infrastructure, demand for integrated cloud-based dispensing systems, and increased use of modular systems in flexible lab automation environments), and challenges (stringent regulatory validation processes, interoperability issues between dispensing systems and lab information systems, supply chain disruptions affecting critical dispensing components, and resistance from traditional labs in adopting automated workflows) influencing the growth of healthcare dispensing systems market).
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the healthcare dispensing systems market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of healthcare dispensing systems across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the healthcare dispensing systems market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the healthcare dispensing systems market.
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35
1.3.2 INCLUSIONS & EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY 38
1.5 STAKEHOLDERS 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY DATA 42
2.1.2.1 Key data from primary sources 43
2.1.2.2 Breakdown of primary sources 45
2.2 MARKET SIZE ESTIMATION 45
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 53
2.4 RESEARCH ASSUMPTIONS 55
2.4.1 MARKET SIZING ASSUMPTIONS 55
2.4.2 OVERALL STUDY ASSUMPTIONS 55
2.5 RISK ASSESSMENT 56
2.6 RESEARCH LIMITATIONS 56
2.6.1 METHODOLOGY-RELATED LIMITATIONS 56
2.6.2 SCOPE-RELATED LIMITATIONS 56
3 EXECUTIVE SUMMARY 57
4 PREMIUM INSIGHTS 61
4.1 HEALTHCARE DISPENSING SYSTEMS MARKET OVERVIEW 61
4.2 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION 62
4.3 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER & REGION 63
4.4 HEALTHCARE DISPENSING SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64
4.5 HEALTHCARE DISPENSING SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.1.1 DRIVERS 67
5.1.1.1 Innovation in artificial intelligence and robotic systems 67
5.1.1.2 Biotech and medtech R&D expansion 68
5.1.1.3 Workflow optimization and lab digitization 68
5.1.1.4 Government incentives for advanced manufacturing 69
5.1.2 RESTRAINTS 69
5.1.2.1 High cost of healthcare dispensing systems 69
5.1.2.2 Regulatory and validation burdens 70
5.1.2.3 Limited infrastructure in emerging markets 70
5.1.3 OPPORTUNITIES 70
5.1.3.1 Growing demand from emerging biotech hubs 70
5.1.3.2 Growing partnerships and collaborations 71
5.1.3.3 Increasing healthcare spending across regions 71
5.1.4 CHALLENGES 72
5.1.4.1 System integration challenges with existing laboratory infrastructure 72
5.1.4.2 Shortage of skilled workforce for operating advanced labs 72
5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
5.3 INDUSTRY TRENDS 74
5.3.1 AUTOMATION AND ROBOTICS ADOPTION 74
5.3.2 AI AND MACHINE LEARNING INTEGRATION 74
5.4 ECOSYSTEM ANALYSIS 74
5.5 VALUE CHAIN ANALYSIS 76
5.6 TECHNOLOGY ANALYSIS 78
5.6.1 KEY TECHNOLOGIES 78
5.6.1.1 Non-contact dispensing technologies 78
5.6.1.2 Pressure-based microfluidic dispensing 78
5.6.1.3 Robotic automation & vision systems 79
5.6.2 COMPLEMENTARY TECHNOLOGIES 79
5.6.2.1 Laboratory information management systems (LIMS) 79
5.6.2.2 Computer-aided design and manufacturing (CAD/CAM) systems 79
5.6.3 ADJACENT TECHNOLOGIES 80
5.6.3.1 Digital twin technology 80
5.6.3.2 3D printing in healthcare dispensing ecosystems 81
5.6.3.3 AI-driven predictive maintenance for dispensing systems 81
5.7 REGULATORY ANALYSIS 81
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.7.2 REGULATORY ANALYSIS 85
5.7.2.1 North America 85
5.7.2.2 Europe 86
5.7.2.3 Asia Pacific 87
5.7.2.4 Middle East & Africa 88
5.7.2.5 Latin America 89
5.8 PRICING ANALYSIS 90
5.8.1 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS, BY PRODUCT (2024) 90
5.8.2 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2024 91
5.9 PORTER’S FIVE FORCES ANALYSIS 92
5.9.1 INTENSITY OF COMPETITIVE RIVALRY 94
5.9.2 BARGAINING POWER OF BUYERS 94
5.9.3 THREAT OF SUBSTITUTES 94
5.9.4 THREAT OF NEW ENTRANTS 94
5.9.5 BARGAINING POWER OF SUPPLIERS 95
5.10 PATENT ANALYSIS 95
5.10.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE DISPENSING SYSTEMS MARKET 95
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE DISPENSING SYSTEMS MARKET 96
5.10.3 MAJOR PATENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET 97
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 97
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
5.11.2 KEY BUYING CRITERIA 98
5.12 END-USER ANALYSIS 99
5.12.1 UNMET NEEDS 99
5.12.2 END-USER EXPECTATIONS 100
5.13 KEY CONFERENCES & EVENTS, 2025–2026 101
5.14 CASE STUDY ANALYSIS 102
5.15 TRADE ANALYSIS 104
5.15.1 IMPORT SCENARIO (HS CODE 8413) 104
5.15.2 EXPORT SCENARIO (HS CODE 8413) 105
5.16 INVESTMENT & FUNDING SCENARIO 106
5.17 IMPACT OF 2025 US TARIFFS ON HEALTHCARE DISPENSING SYSTEMS MARKET 109
5.17.1 KEY TARIFF RATES 109
5.17.2 PRICE IMPACT ANALYSIS 110
5.17.3 IMPACT ON COUNTRY/REGION 110
5.17.3.1 US 110
5.17.3.2 Europe 112
5.17.3.3 APAC 113
5.17.4 IMPACT ON END-USE INDUSTRIES 113
6 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE 115
6.1 INTRODUCTION 116
6.2 AUTOMATIC DISPENSING SYSTEMS 117
6.2.1 GROWING DEMAND FOR PRECISION, STERILITY, AND LAB AUTOMATION TO BOOST ADOPTION OF AUTOMATIC DISPENSING SYSTEMS 117
6.3 SEMI-AUTOMATIC DISPENSING SYSTEMS 118
6.3.1 RISING R&D AND MID-VOLUME LAB DEMAND TO DRIVE DEMAND FOR COST-EFFECTIVE SEMI-AUTOMATED DISPENSING SYSTEMS 118
6.4 STANDALONE/MANUAL DISPENSING SYSTEMS 119
6.4.1 VITAL ROLE OF MANUAL DISPENSING TOOLS IN LOW-RESOURCE, HIGH-CUSTOMIZATION LAB SETTINGS TO SUPPORT MARKET GROWTH 119
6.5 OEM/DISPENSING COMPONENTS 120
6.5.1 PUMPS 121
6.5.1.1 Ability of precision pumps to power sterile, compliant fluid handling across healthcare workflows to drive growth 121
6.5.2 VALVES & NOZZLES 122
6.5.2.1 Ability of valves & nozzles to enable precision, contamination-free fluid control in automated dispensing to boost market 122
6.5.3 CONTROL SYSTEMS 123
6.5.3.1 Ability of control systems to drive intelligent, compliant automation in healthcare dispensing to contribute to growth 123
6.5.4 OTHER OEM COMPONENTS 124
7 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL 125
7.1 INTRODUCTION 126
7.2 LIQUIDS 126
7.2.1 REAGENTS 127
7.2.1.1 Growing automation needs in diagnostics, genomics, and biomanufacturing to boost demand for reagent dispensing systems 127
7.2.2 BUFFERS 128
7.2.2.1 High demand for scalable, validated workflows in biologics and diagnostics to boost market for buffer dispensing systems 128
7.2.3 ANTIBODIES 129
7.2.3.1 Rising demand for ultra-precise diagnostic and therapeutic applications to boost demand for antibody dispensing systems 129
7.2.4 OTHER LIQUIDS 130
7.3 POWDERS, GRANULES, AND LYOPHILIZED MATERIALS 131
7.3.1 CAKES 132
7.3.1.1 Growing demand for high-precision injectable and diagnostic products to boost market for lyophilized cake dispensing 132
7.3.2 LYOBEADS 133
7.3.2.1 Ability of lyobeads to power cold chain-free diagnostics and therapeutics to drive growth 133
7.3.3 OTHER POWDERS, GRANULES, AND LYOPHILIZED MATERIALS 134
7.4 OTHER MATERIALS 135
8 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION 137
8.1 INTRODUCTION 138
8.2 PHARMACEUTICAL & BIOTECHNOLOGY 138
8.2.1 R&D 139
8.2.1.1 Pivotal role of R&D in precise dispensing systems to support growth 139
8.2.2 MANUFACTURING & QA/QC 140
8.2.2.1 Advancing quality control with intelligent dispensing in pharma & biotech manufacturing to fuel growth 140
8.3 DIAGNOSTICS & POC TESTING 141
8.3.1 LATERAL FLOW ASSAYS & RAPID TESTS 143
8.3.1.1 Ability of these tests to enable scalable production with precision dispensing systems to boost market 143
8.3.2 PCR & NUCLEIC ACID TESTS 143
8.3.2.1 Ability of dispensing systems to advance PCR & NAAT efficiency to fuel growth 143
8.3.3 IMMUNOASSAYS & ELISA TESTS 144
8.3.3.1 Ability of automated dispensing systems to power high-throughput immunoassays to propel growth 144
8.3.4 MICROARRAYS 145
8.3.4.1 High-density assay precision with advanced dispensing systems to drive demand 145
8.3.5 IMMUNOBLOTS 146
8.3.5.1 Growing need to automate immunoblot workflows to drive market 146
8.3.6 MICROFLUIDICS & LAB-ON-A-CHIP TESTS 147
8.3.6.1 Advantages of dispensing systems in microfluidic and lab-on-a-chip technologies to support market 147
8.3.7 OTHER DIAGNOSTICS & POC TESTING APPLICATIONS 147
8.4 MEDICAL DEVICE MANUFACTURING 148
8.4.1 DRUG DELIVERY DEVICES 150
8.4.1.1 Advantages such as precision filling and coating with advanced dispensing systems to boost market 150
8.4.2 IMPLANTABLE MEDICAL DEVICES 150
8.4.2.1 Growing need for dispensing of coatings, drug layers, and biocompatible materials to support market 150
8.4.3 SURGICAL INSTRUMENTS & WOUND CARE DEVICES 151
8.4.3.1 Ability of dispensing systems to drive quality and sterility in surgical and wound care devices to fuel growth 151
8.4.4 DIAGNOSTIC TEST KIT MANUFACTURING 152
8.4.4.1 Vital role of dispensing technologies in supporting medical-grade devices to drive growth 152
8.4.5 OTHER MEDICAL DEVICE MANUFACTURING APPLICATIONS 153
8.5 PHARMACY MANAGEMENT 154
8.5.1 INCREASING INTEGRATION OF DISPENSING SYSTEMS IN PHARMACY MANAGEMENT TO DRIVE GROWTH 154
8.6 OTHER APPLICATIONS 155
9 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER 157
9.1 INTRODUCTION 158
9.2 HEALTHCARE PROVIDERS 158
9.2.1 HOSPITALS 160
9.2.1.1 High test volumes and strong push for automation to boost market growth 160
9.2.2 DIAGNOSTIC LABS 161
9.2.2.1 Need for precise, high-throughput dispensing in clinical testing to drive demand in diagnostic labs 161
9.2.3 OUTPATIENT SETTINGS 162
9.2.3.1 Need for patient safety in outpatient settings to boost segmental growth 162
9.2.4 HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES 163
9.2.4.1 Need to support decentralized, high-throughput care and ensure regulatory compliance to boost adoption 163
9.2.5 PHARMACIES 164
9.2.5.1 Growing need for technology to assist with faster prescription filling and medication dispensing to drive market growth 164
9.2.6 OTHER HEALTHCARE PROVIDERS 165
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 166
9.3.1 GROWING IMPORTANCE OF AUTOMATION TO ENHANCE DRUG DEVELOPMENT SPEED AND ACCURACY TO BOOST DEMAND 166
9.4 MEDTECH COMPANIES 167
9.4.1 GROWING ADOPTION OF PRECISION DISPENSING SYSTEMS TO SUPPORT DEVICE MINIATURIZATION 167
9.5 OTHER END USERS 168
10 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION 170
10.1 INTRODUCTION 171
10.2 NORTH AMERICA 171
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 172
10.2.2 US 179
10.2.2.1 US to dominate North American healthcare dispensing systems market 179
10.2.3 CANADA 185
10.2.3.1 Strong demand for pharmacy automation to propel market 185
10.3 EUROPE 190
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 191
10.3.2 GERMANY 198
10.3.2.1 Germany to dominate European healthcare dispensing systems market during forecast period 198
10.3.3 UK 204
10.3.3.1 Strong support for life science R&D and well-developed infrastructure to aid market 204
10.3.4 FRANCE 210
10.3.4.1 Increasing investment in R&D and funding for life sciences to drive growth 210
10.3.5 ITALY 216
10.3.5.1 Advancements in laboratory systems to drive growth 216
10.3.6 SPAIN 222
10.3.6.1 Expanding medical diagnostics research to propel market growth 222
10.3.7 REST OF EUROPE 228
10.4 ASIA PACIFIC 234
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 236
10.4.2 CHINA 242
10.4.2.1 China to grow at highest growth rate during forecast period 242
10.4.3 JAPAN 248
10.4.3.1 Japan to dominate Asia Pacific healthcare dispensing systems market 248
10.4.4 INDIA 254
10.4.4.1 Expansion of biotech sector, coupled with supportive government policies, to fuel market growth 254
10.4.5 REST OF ASIA 260
10.5 LATIN AMERICA 266
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 266
10.5.2 BRAZIL 273
10.5.2.1 Growing public and private initiatives supporting scientific research to drive growth 273
10.5.3 MEXICO 278
10.5.3.1 Thriving pharmaceutical industry to drive market 278
10.5.4 REST OF LATIN AMERICA 284
10.6 MIDDLE EAST & AFRICA 290
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 290
10.6.2 GCC COUNTRIES 297
10.6.2.1 Improvements in healthcare infrastructure to support market growth 297
10.6.3 REST OF MIDDLE EAST & AFRICA 302
11 COMPETITIVE LANDSCAPE 309
11.1 OVERVIEW 309
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 309
11.3 REVENUE ANALYSIS, 2020–2024 313
11.4 MARKET SHARE ANALYSIS, 2024 314
11.5 RANKING OF KEY MARKET PLAYERS 318
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 318
11.6.1 STARS 319
11.6.2 EMERGING LEADERS 319
11.6.3 PERVASIVE PLAYERS 319
11.6.4 PARTICIPANTS 319
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 321
11.6.5.1 Company footprint 321
11.6.5.2 Region footprint 322
11.6.5.3 Type footprint 323
11.6.5.4 Material footprint 324
11.6.5.5 Application footprint 325
11.6.5.6 End-user footprint 326
11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 327
11.7.1 PROGRESSIVE COMPANIES 327
11.7.2 RESPONSIVE COMPANIES 327
11.7.3 DYNAMIC COMPANIES 327
11.7.4 STARTING BLOCKS 327
11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 328
11.7.5.1 Detailed list of key startups/SMEs 328
11.7.5.2 Competitive benchmarking of startups/SMEs 329
11.8 COMPANY VALUATION & FINANCIAL METRICS 330
11.9 BRAND/PRODUCT COMPARISON 331
11.10 COMPETITIVE SCENARIO 332
11.10.1 PRODUCT LAUNCHES 332
11.10.2 DEALS 334
11.10.3 EXPANSIONS 336
12 COMPANY PROFILES 337
12.1 KEY PLAYERS 337
12.1.1 NORDSON CORPORATION 337
12.1.1.1 Business overview 337
12.1.1.2 Products offered 339
12.1.1.3 Recent developments 342
12.1.1.3.1 Product launches 342
12.1.1.3.2 Deals 342
12.1.1.3.3 Expansions 343
12.1.1.4 MnM view 343
12.1.1.4.1 Right to win 343
12.1.1.4.2 Strategic choices 343
12.1.1.4.3 Weaknesses & competitive threats 343
12.1.2 AGILENT TECHNOLOGIES, INC. 344
12.1.2.1 Business overview 344
12.1.2.2 Products offered 346
12.1.2.3 Recent developments 346
12.1.2.3.1 Product launches 346
12.1.2.3.2 Deals 347
12.1.2.4 MnM view 347
12.1.2.4.1 Right to win 347
12.1.2.4.2 Strategic choices 347
12.1.2.4.3 Weaknesses & competitive threats 347
12.1.3 DANAHER CORPORATION 348
12.1.3.1 Business overview 348
12.1.3.2 Products offered 350
12.1.3.3 Recent developments 350
12.1.3.3.1 Deals 350
12.1.3.4 MnM view 351
12.1.3.4.1 Right to win 351
12.1.3.4.2 Strategic choices 351
12.1.3.4.3 Weaknesses & competitive threats 351
12.1.4 THERMO FISHER SCIENTIFIC INC. 352
12.1.4.1 Business overview 352
12.1.4.2 Products offered 354
12.1.4.3 Recent developments 355
12.1.4.3.1 Expansions 355
12.1.4.4 MnM view 355
12.1.4.4.1 Right to win 355
12.1.4.4.2 Strategic choices 355
12.1.4.4.3 Weaknesses & competitive threats 356
12.1.5 BIODOT 357
12.1.5.1 Business overview 357
12.1.5.2 Products offered 357
12.1.5.3 Recent developments 358
12.1.5.3.1 Product launches 358
12.1.5.3.2 Deals 359
12.1.5.4 MnM view 359
12.1.5.4.1 Right to win 359
12.1.5.4.2 Strategic choices 359
12.1.5.4.3 Weaknesses & competitive threats 359
12.1.6 FISNAR 360
12.1.6.1 Business overview 360
12.1.6.2 Products offered 360
12.1.7 PARKER-HANNIFIN CORPORATION 363
12.1.7.1 Business overview 363
12.1.7.2 Products offered 364
12.1.8 BDTRONIC 365
12.1.8.1 Business overview 365
12.1.8.2 Products offered 365
12.1.9 HAMILTON COMPANY 367
12.1.9.1 Business overview 367
12.1.9.2 Products offered 367
12.1.9.3 Recent developments 368
12.1.9.3.1 Product launches 368
12.1.9.3.2 Deals 369
12.1.10 GRACO INC. 370
12.1.10.1 Business overview 370
12.1.10.2 Products offered 372
12.1.10.3 Recent developments 372
12.1.10.3.1 Product launches 372
12.1.11 REVVITY, INC. 373
12.1.11.1 Business overview 373
12.1.11.2 Products offered 375
12.1.12 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH 377
12.1.12.1 Business overview 377
12.1.12.2 Products offered 377
12.1.12.3 Recent developments 378
12.1.12.3.1 Deals 378
12.1.13 TECAN TRADING AG 379
12.1.13.1 Business overview 379
12.1.13.2 Products offered 380
12.1.14 IVEK CORPORATION 382
12.1.14.1 Business overview 382
12.1.14.2 Products offered 382
12.1.15 IMAGENE TECHNOLOGY INC. 384
12.1.15.1 Business overview 384
12.1.15.2 Products offered 384
12.1.16 QIAGEN 385
12.1.16.1 Business overview 385
12.1.16.2 Products offered 387
12.1.17 BRAND GMBH + CO KG 388
12.1.17.1 Business overview 388
12.1.17.2 Products offered 388
12.1.18 ASCENTIAL TECHNOLOGIES 389
12.1.18.1 Business overview 389
12.1.18.2 Products offered 389
12.1.18.3 Recent developments 390
12.1.18.3.1 Expansions 390
12.1.18.3.2 Other developments 390
12.1.19 LGC BIOSEARCH TECHNOLOGIES 391
12.1.19.1 Business overview 391
12.1.19.2 Products offered 391
12.1.19.3 Recent developments 392
12.1.19.3.1 Deals 392
12.1.20 GILSON INCORPORATED 393
12.1.20.1 Business overview 393
12.1.20.2 Products offered 393
12.2 OTHER PLAYERS 394
12.2.1 CLAREMONT BIOSOLUTIONS, LLC 394
12.2.2 GUANGZHOU ASCEND PRECISION MACHINERY CO., LTD. 395
12.2.3 RADETEC PTY LTD. 396
12.2.4 BAODING CHUANGRUI PRECISION PUMP CO., LTD. 397
12.2.5 ELVEFLOW 398
13 APPENDIX 399
13.1 DISCUSSION GUIDE 399
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 404
13.3 CUSTOMIZATION OPTIONS 406
13.4 RELATED REPORTS 407
13.5 AUTHOR DETAILS 408
LIST OF TABLES
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38
TABLE 2 HEALTHCARE DISPENSING SYSTEMS MARKET: FACTOR ANALYSIS 51
TABLE 3 HEALTHCARE DISPENSING SYSTEMS MARKET: RISK ASSESSMENT 56
TABLE 4 HEALTHCARE DISPENSING SYSTEMS MARKET: MARKET DYNAMICS 67
TABLE 5 HEALTHCARE DISPENSING SYSTEMS MARKET: ROLE IN ECOSYSTEM 76
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 11 REGULATORY SCENARIO OF NORTH AMERICA 85
TABLE 12 REGULATORY SCENARIO OF EUROPE 86
TABLE 13 REGULATORY SCENARIO OF ASIA PACIFIC 87
TABLE 14 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 88
TABLE 15 REGULATORY SCENARIO OF LATIN AMERICA 89
TABLE 16 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS MARKET, BY PRODUCT (2024) 91
TABLE 17 INDICATIVE PRICING OF HEALTHCARE DISPENSING SYSTEMS, BY REGION, 2024 92
TABLE 18 HEALTHCARE DISPENSING SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 93
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRODUCTS, BY END USER (%) 98
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE DISPENSING SYSTEMS FOR KEY END USERS 99
TABLE 21 UNMET NEEDS IN HEALTHCARE DISPENSING SYSTEMS MARKET 99
TABLE 22 END-USER EXPECTATIONS IN HEALTHCARE DISPENSING SYSTEMS MARKET 100
TABLE 23 LIST OF KEY CONFERENCES & EVENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET, JANUARY 2025–DECEMBER 2026 101
TABLE 24 CASE STUDY 1: AUTOMATING BIOREACTOR WORKFLOWS WITH CELLEXUS & WATSON-MARLOW PUMPS 102
TABLE 25 CASE STUDY 2: REDUCING MEDICATION RE-DISPENSES THROUGH BARCODE-ENABLED DISPENSING SYSTEM INTEGRATION AT A U.S. HEALTH SYSTEM 103
TABLE 26 CASE STUDY 3: SCALING PRESCRIPTION FULFILLMENT WITH AN AUTOMATED DISPENSING SYSTEM FOR HIGH-VOLUME PHARMACY OPERATIONS 103
TABLE 27 IMPORT SCENARIO FOR PUMPS FOR LIQUIDS, WHETHER OR NOT FITTED WITH A MEASURING DEVICE [EXCL. (HS CODE 8413)], BY COUNTRY, 2020–2024 (USD THOUSAND) 104
TABLE 28 EXPORT SCENARIO FOR PUMPS FOR LIQUIDS, WHETHER OR NOT FITTED WITH A MEASURING DEVICE [EXCL. (HS CODE 8413)], BY COUNTRY, 2020–2024 (USD THOUSAND) 105
TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES 109
TABLE 30 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 116
TABLE 31 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS) 116
TABLE 32 AUTOMATIC DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 33 SEMI-AUTOMATIC DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 34 STANDALONE/MANUAL DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 119
TABLE 35 OEM/DISPENSING COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 36 OEM/DISPENSING COMPONENTS MARKET FOR PUMPS, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 37 OEM/DISPENSING COMPONENTS MARKET FOR VALVES & NOZZLES, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 38 OEM/DISPENSING COMPONENTS MARKET FOR CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 123
TABLE 39 OTHER OEM/DISPENSING COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 40 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 126
TABLE 41 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 42 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 127
TABLE 43 HEALTHCARE DISPENSING SYSTEMS MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 44 HEALTHCARE DISPENSING SYSTEMS MARKET FOR BUFFERS, BY REGION, 2023–2030 (USD MILLION) 129
TABLE 45 HEALTHCARE DISPENSING SYSTEMS MARKET FOR ANTIBODIES, BY REGION, 2023–2030 (USD MILLION) 130
TABLE 46 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER LIQUIDS, BY REGION, 2023–2030 (USD MILLION) 131
TABLE 47 HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY REGION, 2023–2030 (USD MILLION) 132
TABLE 48 HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 132
TABLE 49 HEALTHCARE DISPENSING SYSTEMS MARKET FOR CAKES, BY REGION, 2023–2030 (USD MILLION) 133
TABLE 50 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LYOBEADS, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 51 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY REGION, 2023–2030 (USD MILLION) 135
TABLE 52 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER MATERIALS, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 53 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138
TABLE 54 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 55 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 139
TABLE 56 HEALTHCARE DISPENSING SYSTEMS MARKET FOR R&D APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 140
TABLE 57 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MANUFACTURING & QA/QC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 58 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 142
TABLE 59 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 60 HEALTHCARE DISPENSING SYSTEMS MARKET FOR LATERAL FLOW ASSAYS & RAPID TESTS, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 61 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PCR & NUCLEIC ACID TESTS, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 62 HEALTHCARE DISPENSING SYSTEMS MARKET FOR IMMUNOASSAYS & ELISA TESTS, BY REGION, 2023–2030 (USD MILLION) 145
TABLE 63 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (USD MILLION) 146
TABLE 64 HEALTHCARE DISPENSING SYSTEMS MARKET FOR IMMUNOBLOTS, BY REGION, 2023–2030 (USD MILLION) 146
TABLE 65 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MICROFLUIDICS & LAB-ON-A-CHIP TESTS, BY REGION, 2023–2030 (USD MILLION) 147
TABLE 66 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER DIAGNOSTICS & POC TESTING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 67 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 149
TABLE 68 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 69 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DRUG DELIVERY DEVICES, BY REGION, 2023–2030 (USD MILLION) 150
TABLE 70 HEALTHCARE DISPENSING SYSTEMS MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 71 HEALTHCARE DISPENSING SYSTEMS MARKET FOR SURGICAL INSTRUMENTS & WOUND CARE DEVICES, BY REGION, 2023–2030 (USD MILLION) 152
TABLE 72 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTIC TEST KIT MANUFACTURING, BY REGION, 2023–2030 (USD MILLION) 153
TABLE 73 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 74 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACY MANAGEMENT APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 155
TABLE 75 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 156
TABLE 76 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 158
TABLE 77 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 159
TABLE 78 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 79 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 80 HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTIC LABS, BY REGION, 2023–2030 (USD MILLION) 162
TABLE 81 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OUTPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION) 163
TABLE 82 HEALTHCARE DISPENSING SYSTEMS MARKET FOR HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES, BY REGION, 2023–2030 (USD MILLION) 164
TABLE 83 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACIES, BY REGION, 2023–2030 (USD MILLION) 165
TABLE 84 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 166
TABLE 85 HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 167
TABLE 86 HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 168
TABLE 87 HEALTHCARE DISPENSING SYSTEMS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 169
TABLE 88 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 171
TABLE 89 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 90 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 91 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 92 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 174
TABLE 93 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 94 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 95 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176
TABLE 96 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 97 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 98 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 99 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 178
TABLE 100 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 101 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 102 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 103 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 180
TABLE 104 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 105 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 106 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182
TABLE 107 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 108 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 109 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 110 US: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 184
TABLE 111 US: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 112 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 113 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 114 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 186
TABLE 115 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 116 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 117 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 188
TABLE 118 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 119 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 120 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 121 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 190
TABLE 122 CANADA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 123 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 124 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 125 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 126 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 193
TABLE 127 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 128 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 129 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 195
TABLE 130 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 131 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 132 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 133 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 197
TABLE 134 EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 135 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 136 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 137 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 199
TABLE 138 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 139 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 140 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 201
TABLE 141 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 142 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 143 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 144 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 203
TABLE 145 GERMANY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 146 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 147 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 148 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 205
TABLE 149 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 150 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 151 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 207
TABLE 152 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 153 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 154 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 155 UK: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 209
TABLE 156 UK: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 157 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 158 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 159 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 211
TABLE 160 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 161 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 162 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 213
TABLE 163 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 164 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 165 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 166 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 215
TABLE 167 FRANCE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 168 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 169 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 170 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 217
TABLE 171 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 172 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 173 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 219
TABLE 174 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 175 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 176 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 220
TABLE 177 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 221
TABLE 178 ITALY: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 179 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 180 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 181 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 223
TABLE 182 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 183 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 184 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225
TABLE 185 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 186 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 187 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 188 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 227
TABLE 189 SPAIN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 190 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 191 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 192 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 229
TABLE 193 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 194 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 195 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 231
TABLE 196 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 197 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 198 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 199 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 233
TABLE 200 REST OF EUROPE: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 201 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 236
TABLE 202 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 203 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 204 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 238
TABLE 205 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 206 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 207 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239
TABLE 208 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 209 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 210 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 211 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 241
TABLE 212 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 213 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 214 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 215 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 244
TABLE 216 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 217 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 218 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245
TABLE 219 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 220 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 221 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 222 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 247
TABLE 223 CHINA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 224 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 225 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 226 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 250
TABLE 227 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 228 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 251
TABLE 229 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 251
TABLE 230 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 231 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 232 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 233 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 253
TABLE 234 JAPAN: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 235 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 236 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 237 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 256
TABLE 238 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 239 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 240 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 257
TABLE 241 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 242 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 243 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 244 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 259
TABLE 245 INDIA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 246 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 247 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 261
TABLE 248 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 262
TABLE 249 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 250 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 251 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 263
TABLE 252 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 253 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 254 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 255 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 265
TABLE 256 REST OF ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 257 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 267
TABLE 258 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267
TABLE 259 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 260 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 268
TABLE 261 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 262 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 263 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270
TABLE 264 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 265 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 266 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 267 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 272
TABLE 268 LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 269 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 270 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 274
TABLE 271 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 274
TABLE 272 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 273 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 274 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276
TABLE 275 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 276 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 277 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 278 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 278
TABLE 279 BRAZIL: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 278
TABLE 280 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 281 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 282 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 280
TABLE 283 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 284 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 285 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 281
TABLE 286 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 282
TABLE 287 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 282
TABLE 288 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 289 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 283
TABLE 290 MEXICO: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 284
TABLE 291 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 292 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 285
TABLE 293 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 286
TABLE 294 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 295 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 296 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 287
TABLE 297 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 298 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 299 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 289
TABLE 300 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 289
TABLE 301 REST OF LATIN AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 302 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 291
TABLE 303 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 304 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 305 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 292
TABLE 306 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 307 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 308 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 294
TABLE 309 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 310 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 295
TABLE 311 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 295
TABLE 312 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 296
TABLE 313 MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 314 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 297
TABLE 315 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 298
TABLE 316 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 298
TABLE 317 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 318 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 319 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 300
TABLE 320 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 321 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 322 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 323 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 302
TABLE 324 GCC COUNTRIES: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 325 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 303
TABLE 326 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR OEM/DISPENSING COMPONENTS, BY TYPE, 2023–2030 (USD MILLION) 303
TABLE 327 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 304
TABLE 328 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR LIQUIDS, BY TYPE, 2023–2030 (USD MILLION) 304
TABLE 329 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR POWDERS, GRANULES, AND LYOPHILIZED MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 330 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 305
TABLE 331 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 332 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR DIAGNOSTICS & POC TESTING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 333 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR MEDICAL DEVICE MANUFACTURING APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 334 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION) 307
TABLE 335 REST OF MIDDLE EAST & AFRICA: HEALTHCARE DISPENSING SYSTEMS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 308
TABLE 336 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET, JANUARY 2022–JUNE 2025 310
TABLE 337 HEALTHCARE DISPENSING SYSTEMS MARKET: DEGREE OF COMPETITION 315
TABLE 338 HEALTHCARE DISPENSING SYSTEMS MARKET: REGION FOOTPRINT 322
TABLE 339 HEALTHCARE DISPENSING SYSTEMS MARKET: TYPE FOOTPRINT 323
TABLE 340 HEALTHCARE DISPENSING SYSTEMS MARKET: MATERIAL FOOTPRINT 324
TABLE 341 HEALTHCARE DISPENSING SYSTEMS MARKET: APPLICATION FOOTPRINT 325
TABLE 342 HEALTHCARE DISPENSING SYSTEMS MARKET: END-USER FOOTPRINT 326
TABLE 343 HEALTHCARE DISPENSING SYSTEMS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 328
TABLE 344 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 329
TABLE 345 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY TYPE 329
TABLE 346 HEALTHCARE DISPENSING SYSTEMS MARKET: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 333
TABLE 347 HEALTHCARE DISPENSING SYSTEMS MARKET: DEALS, JANUARY 2022–JULY 2025 334
TABLE 348 HEALTHCARE DISPENSING SYSTEMS MARKET: EXPANSIONS,
JANUARY 2022–MAY 2025 336
TABLE 349 NORDSON CORPORATION: COMPANY OVERVIEW 337
TABLE 350 NORDSON CORPORATION: PRODUCTS OFFERED 339
TABLE 351 NORDSON CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 342
TABLE 352 NORDSON CORPORATION: DEALS, JANUARY 2022–MAY 2025 342
TABLE 353 NORDSON CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025 343
TABLE 354 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 344
TABLE 355 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 346
TABLE 356 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 346
TABLE 357 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–MAY 2025 347
TABLE 358 DANAHER CORPORATION: COMPANY OVERVIEW 348
TABLE 359 DANAHER CORPORATION: PRODUCTS OFFERED 350
TABLE 360 DANAHER CORPORATION: DEALS, JANUARY 2022–MAY 2025 350
TABLE 361 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 352
TABLE 362 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 354
TABLE 363 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–MAY 2025 355
TABLE 364 BIODOT: COMPANY OVERVIEW 357
TABLE 365 BIODOT: PRODUCTS OFFERED 357
TABLE 366 BIODOT: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025 358
TABLE 367 BIODOT: DEALS, JANUARY 2022– MAY 2025 359
TABLE 368 FISNAR: COMPANY OVERVIEW 360
TABLE 369 FISNAR: PRODUCTS OFFERED 360
TABLE 370 PARKER-HANNIFIN CORPORATION: COMPANY OVERVIEW 363
TABLE 371 PARKER-HANNIFIN CORPORATION: PRODUCTS OFFERED 364
TABLE 372 BDTRONIC: COMPANY OVERVIEW 365
TABLE 373 BDTRONIC: PRODUCTS OFFERED 365
TABLE 374 HAMILTON COMPANY: COMPANY OVERVIEW 367
TABLE 375 HAMILTON COMPANY: PRODUCTS OFFERED 367
TABLE 376 HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 368
TABLE 377 HAMILTON COMPANY: DEALS, JANUARY 2022–MAY 2025 369
TABLE 378 GRACO INC.: COMPANY OVERVIEW 370
TABLE 379 GRACO INC.: PRODUCTS OFFERED 372
TABLE 380 GRACO INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 372
TABLE 381 REVVITY, INC.: COMPANY OVERVIEW 373
TABLE 382 REVVITY, INC.: PRODUCTS OFFERED 375
TABLE 383 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH: COMPANY OVERVIEW 377
TABLE 384 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH: PRODUCTS OFFERED 377
TABLE 385 HARRO HÖFLIGER VERPACKUNGSMASCHINEN GMBH: DEALS, JANUARY 2022–MAY 2025 378
TABLE 386 TECAN TRADING AG: COMPANY OVERVIEW 379
TABLE 387 TECAN TRADING AG: PRODUCTS OFFERED 380
TABLE 388 IVEK CORPORATION: COMPANY OVERVIEW 382
TABLE 389 IVEK CORPORATION: PRODUCTS OFFERED 382
TABLE 390 IMAGENE TECHNOLOGY INC.: COMPANY OVERVIEW 384
TABLE 391 IMAGENE TECHNOLOGY INC.: PRODUCTS OFFERED 384
TABLE 392 QIAGEN: COMPANY OVERVIEW 385
TABLE 393 QIAGEN: PRODUCTS OFFERED 387
TABLE 394 BRAND GMBH + CO KG: COMPANY OVERVIEW 388
TABLE 395 BRAND GMBH + CO KG: PRODUCTS OFFERED 388
TABLE 396 ASCENTIAL TECHNOLOGIES: COMPANY OVERVIEW 389
TABLE 397 ASCENTIAL TECHNOLOGIES: PRODUCTS OFFERED 389
TABLE 398 ASCENTIAL TECHNOLOGIES: EXPANSIONS, JANUARY 2022–MAY 2025 390
TABLE 399 ASCENTIAL TECHNOLOGIES: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 390
TABLE 400 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW 391
TABLE 401 LGC BIOSEARCH TECHNOLOGIES: PRODUCTS OFFERED 391
TABLE 402 LGC BIOSEARCH TECHNOLOGIES: DEALS, JANUARY 2022–MAY 2025 392
TABLE 403 GILSON INCORPORATED: COMPANY OVERVIEW 393
TABLE 404 GILSON INCORPORATED: PRODUCTS OFFERED 393
TABLE 405 CLAREMONT BIOSOLUTIONS, LLC: COMPANY OVERVIEW 394
TABLE 406 GUANGZHOU ASCEND PRECISION MACHINERY CO., LTD.: COMPANY OVERVIEW 395
TABLE 407 RADETEC PTY LTD.: COMPANY OVERVIEW 396
TABLE 408 BAODING CHUANGRUI PRECISION PUMP CO., LTD.: COMPANY OVERVIEW 397
TABLE 409 ELVEFLOW: COMPANY OVERVIEW 398
LIST OF FIGURES
FIGURE 1 HEALTHCARE DISPENSING SYSTEMS MARKET SEGMENTATION & REGIONAL SCOPE 35
FIGURE 2 RESEARCH DESIGN 40
FIGURE 3 PRIMARY SOURCES 42
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 44
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 46
FIGURE 7 HEALTHCARE DISPENSING SYSTEMS MARKET: SUPPLY-SIDE MARKET ESTIMATION 47
FIGURE 8 HEALTHCARE DISPENSING SYSTEMS MARKET: REVENUE ESTIMATION APPROACH 48
FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON HEALTHCARE DISPENSING SYSTEMS 49
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 52
FIGURE 11 HEALTHCARE DISPENSING SYSTEMS MARKET: CAGR PROJECTIONS 52
FIGURE 12 TOP-DOWN APPROACH 53
FIGURE 13 DATA TRIANGULATION METHODOLOGY 54
FIGURE 14 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 57
FIGURE 15 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL, 2025 VS. 2030 (USD MILLION) 58
FIGURE 16 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 58
FIGURE 17 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 59
FIGURE 18 HEALTHCARE DISPENSING SYSTEMS MARKET: GEOGRAPHICAL SNAPSHOT 60
FIGURE 19 GROWING FOCUS ON AUTOMATION DISPENSING AND FAVORABLE GOVERNMENT SUPPORT AND FUNDING TO DRIVE MARKET 61
FIGURE 20 NORTH AMERICA TO DOMINATE HEALTHCARE DISPENSING SYSTEMS MARKET DURING FORECAST PERIOD 62
FIGURE 21 PHARMACEUTICAL COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 63
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 64
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 65
FIGURE 24 HEALTHCARE DISPENSING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
FIGURE 25 HEALTHCARE DISPENSING SYSTEMS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 26 HEALTHCARE DISPENSING SYSTEMS MARKET: ECOSYSTEM ANALYSIS 75
FIGURE 27 HEALTHCARE DISPENSING SYSTEMS MARKET: VALUE CHAIN ANALYSIS 77
FIGURE 28 HEALTHCARE DISPENSING SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 93
FIGURE 29 GLOBAL PATENTS GRANTED IN HEALTHCARE DISPENSING SYSTEMS MARKET, 2015–2024 96
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “REAGENT DISPENSING SYSTEMS” PATENTS (JANUARY 2015–JUNE 2025) 96
FIGURE 31 MAJOR PATENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET (JANUARY 2015–JUNE 2025) 97
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 98
FIGURE 33 KEY BUYING CRITERIA FOR TOP END USERS 99
FIGURE 34 HEALTHCARE DISPENSING SYSTEMS MARKET: IMPORT SCENARIO FOR HS CODE 8413, 2020–2024 104
FIGURE 35 HEALTHCARE DISPENSING SYSTEMS MARKET: EXPORT SCENARIO FOR HS CODE 8413, 2020–2024 105
FIGURE 39 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET SNAPSHOT 172
FIGURE 40 ASIA PACIFIC: HEALTHCARE DISPENSING SYSTEMS MARKET SNAPSHOT 235
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET, 2020–2024 (USD MILLION) 314
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET (2024) 315
FIGURE 43 RANKING OF KEY PLAYERS IN HEALTHCARE DISPENSING SYSTEMS MARKET, 2024 318
FIGURE 44 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 320
FIGURE 45 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPANY FOOTPRINT 321
FIGURE 46 HEALTHCARE DISPENSING SYSTEMS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 328
FIGURE 47 EV/EBITDA OF KEY VENDORS, 2024 330
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF HEALTHCARE DISPENSING SYSTEM VENDORS, 2024 330
FIGURE 49 HEALTHCARE DISPENSING SYSTEMS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 331
FIGURE 50 NORDSON CORPORATION: COMPANY SNAPSHOT (2024) 338
FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 345
FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 349
FIGURE 53 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 353
FIGURE 54 PARKER-HANNIFIN CORPORATION: COMPANY SNAPSHOT (2024) 364
FIGURE 55 GRACO INC.: COMPANY SNAPSHOT (2024) 371
FIGURE 56 REVVITY, INC.: COMPANY SNAPSHOT (2024) 374
FIGURE 57 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 380
FIGURE 58 QIAGEN: COMPANY SNAPSHOT (2024) 386
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11